PMID: 9163667May 1, 1997Paper

Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines

The European Respiratory Journal
E BattistiniG A Rossi

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathological entity with well-defined diagnostic criteria, which can be idiopathic or produced by a variety of biological processes. We describe the occurrence of BOOP in three children, one with acute lymphoblastic leukaemia and two with acute promyelocytic leukaemia. In the three patients, BOOP developed 10-20 days after a course of therapy with cytosine arabinoside and anthracyclines. The possible relationships between the small conducting airway lesions, lung toxic reaction to the drugs and/or nonidentified infectious agents are discussed.

Citations

Apr 25, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Manuel Cobo DolsManuel Benavides Orgaz
Jan 16, 1999·Pediatric Clinics of North America·M Grossi
Mar 18, 2000·Thorax·J F Cordier
Aug 27, 2013·Early Human Development·Salvatore CazzatoSilvia Ghione
Jul 13, 2004·European Journal of Haematology·Georgios KalambokisEpameinondas Tsianos
Sep 9, 2009·British Journal of Haematology·Karine ChagnonAnne Bergeron
Jan 15, 2002·Clinics in Chest Medicine·E H AlhamadF J Martinez
Feb 14, 2006·Seminars in Oncology·Mark MeadorsMichael C Perry
Jun 8, 2001·Critical Care Medicine·A Kornecki, S D Shemie
Sep 18, 2004·Pediatric Pulmonology·Leland L FanClaire Langston
Feb 3, 2009·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Kai Hsiung KoGuo Shu Huang
May 29, 2014·Expert Review of Respiratory Medicine·Maureen B Josephson, Samuel Brian Goldfarb

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.